SCHEMBL2838231

SCHEMBL2838231

CCCC[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.68
▸ SERPINA6 P08185 2/20 0.68
▸ SHBG P04278 2/20 0.68
▸ SLC22A1 O15245 1/20 0.68
▸ THRB P10828 1/20 0.68
▸ LMNA P02545 5/20 0.62
▸ MAPT P10636 2/20 0.62
▸ CYP19A1 P11511 2/20 0.56
▸ PGR P06401 2/20 0.53
▸ HIF1A Q16665 2/20 0.52
▸ MCL1 Q07820 1/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ CYP3A4 P08684 4/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ SLC6A4 P31645 2/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ ABCB11 O95342 2/20 0.48
▸ NR3C1 P04150 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20342396 0.89 ALDH1A1 (0.70) ALDH1A1SERPINA6SHBGSLC22A1THRB
SCHEMBL6357336 0.89 ALDH1A1 (0.70) ALDH1A1SERPINA6SHBGSLC22A1THRB
SCHEMBL13216858 0.88 ALDH1A1 (0.69) ALDH1A1SERPINA6SHBGSLC22A1THRB
SCHEMBL2832494 0.88 ALDH1A1 (0.69) ALDH1A1SERPINA6SHBGSLC22A1THRB
SCHEMBL6714644 0.86 ALDH1A1 (0.64) ALDH1A1SERPINA6SHBGSLC22A1THRB
SCHEMBL7891346 0.85 ALDH1A1 (0.72) ALDH1A1SERPINA6SHBGSLC22A1THRB
SCHEMBL5973336 0.85 ALDH1A1 (0.72) ALDH1A1SERPINA6SHBGSLC22A1THRB
SCHEMBL8396003 0.85 ALDH1A1 (0.65) ALDH1A1SERPINA6SHBGSLC22A1THRB
SCHEMBL7518658 0.84 ALDH1A1 (0.67) ALDH1A1SERPINA6SHBGSLC22A1THRB
SCHEMBL13372738 0.84 ALDH1A1 (0.67) ALDH1A1SERPINA6SHBGSLC22A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6437156-B1 ANTIANXIETY; AFFECTS THE FUNCTION OF THE AUTONOMIC NERVOUS SYSTEM AND A VARIETY OF BEHAVIORAL OR PHYSIOLOGICAL ACTIONS; VOMEROPHERINS; PHEROMONES PHERIN CORPORATION 2002-08-20 — — US claimed
US-20100111896-A1 Items Containing A Human Pheromone Component MARENBERG BARRY J 2010-05-06 — — US disclosed
WO-2007062023-A2 ITEMS CONTAINING A HUMAN PHEROMONE COMPONENT BRAGINSKY PHILIP Y (US) 2007-05-31 — — WO disclosed
EP-0948521-A4 19-NOR-CHOLANE STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN HYPOTHALAMIC FUNCTION PHERIN PHARM INC (US) 2007-01-31 — — EP disclosed
US-6437156-B1 ANTIANXIETY; AFFECTS THE FUNCTION OF THE AUTONOMIC NERVOUS SYSTEM AND A VARIETY OF BEHAVIORAL OR PHYSIOLOGICAL ACTIONS; VOMEROPHERINS; PHEROMONES PHERIN CORPORATION 2002-08-20 — — US disclosed
US-6432938-B1 NASAL ADMINISTERING A STEROID PHERIN CORPORATION 2002-08-13 — — US disclosed
US-6331534-B1 ADMINISTERING EFFECTIVE AMOUNT OF STEROID WITHIN NASAL PASSAGE OF INDIVIDUAL SUCH THAT IT BINDS SPECIFICALLY TO RECEPTORS ON SURFACE OF NASAL NEUROEPITHELIAL CELLS IN VOMERONASAL ORGAN PHERIN PHARMACEUTICALS, INC. 2001-12-18 — — US disclosed
US-6117860-A NASALLY ADMINISTERING STEROID WHICH BINDS TO A SPECIFIC NEUROEPITHELIAL RECEPTOR FOR ALLEVIATING PREMENSTRUAL TENSION AND ANXIETY PHERIN PHARMACEUTICALS, INC. (US) 2000-09-12 — — US disclosed
US-6057439-A EPOXYSTEROIDS PHERIN CORPORATION (US) 2000-05-02 — — US disclosed
EP-0948521-A1 19-NOR-CHOLANE STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN HYPOTHALAMIC FUNCTION Pherin Pharmaceuticals, Inc. (US) 1999-10-13 — — EP disclosed
US-5922699-A AFFECTING CERTAIN CONSEQUENT BEHAVIOR AND PHYSIOLOGY, E.G., THE REDUCTION OF ANXIETY PHERIN CORPORATION (US) 1999-07-13 — — US disclosed
WO-1997046574-A1 19-NOR-CHOLANE STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN HYPOTHALAMIC FUNCTION PHERIN CORPORATION (US) 1997-12-11 — — WO disclosed
Send feedback